Palliative Care Teaching Sessions for Family Caregivers of Patients With Non-Small Cell Lung Cancer
Palliative Care for Quality of Life and Symptom Concerns in Family Caregivers of Lung Cancer Patients
5 other identifiers
interventional
372
1 country
1
Brief Summary
RATIONALE: Palliative care teaching sessions may be more effective than standard care in improving caregiver burden, caregiver skills preparedness, quality of life, and distress in family caregivers of patients with non-small cell lung cancer. PURPOSE: This clinical trial is studying the effects of palliative care teaching sessions in family caregivers of patients with non-small cell lung cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable lung-cancer
Started Sep 2009
Longer than P75 for not_applicable lung-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 21, 2009
CompletedFirst Posted
Study publicly available on registry
January 22, 2009
CompletedStudy Start
First participant enrolled
September 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedAugust 2, 2016
July 1, 2016
5 years
January 21, 2009
July 29, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Caregiver burden
24 weeks post study enrollment
Caregiver skills preparedness
24 weeks post study enrollment
Caregiver quality of life
24 weeks post study enrollment
Caregiver psychological distress
24 weeks post study enrollment
Caregiver self-care behavior
24 weeks post study enrollment
Resource use by caregiver
24 weeks post study enrollment
Identification of a subgroup of caregivers who benefit most from the family caregiver palliative care intervention in relation to sociodemographic characteristics and clinical/functional factors
24 weeks post study enrollment
Study Arms (2)
Phase I-Usual Care
NO INTERVENTIONPhase 2 - Intervention
ACTIVE COMPARATORInterventions
Family Caregiver Palliative Care Intervention at weeks 7, 8, 10, and 12 post study enrollment
Occurs at baseline, 7 weeks, 12 weeks, 18 weeks and 24 weeks post enrollment
Occurs at baseline, 7 weeks, 12 weeks, 18 weeks and 24 weeks post enrollment
Occurs at baseline, 7 weeks, 12 weeks, 18 weeks and 24 weeks post enrollment
Occurs at baseline, 7 weeks, 12 weeks, 18 weeks and 24 weeks post enrollment
Eligibility Criteria
You may qualify if:
- The primary family caregiver as identified by a patient with early or late stage non-small cell lung cancer (NSCLC) participating in Project 1 and 2
- Patients having been accrued to project 1 or project 2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- City of Hope Medical Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
City of Hope Comprehensive Cancer Center
Duarte, California, 91010-3000, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Betty Ferrell, PhD
City of Hope Comprehensive Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 21, 2009
First Posted
January 22, 2009
Study Start
September 1, 2009
Primary Completion
September 1, 2014
Study Completion
September 1, 2014
Last Updated
August 2, 2016
Record last verified: 2016-07